<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03519633</url>
  </required_header>
  <id_info>
    <org_study_id>GYN LPS-CUR 2018</org_study_id>
    <nct_id>NCT03519633</nct_id>
  </id_info>
  <brief_title>Role of Curarization During Anesthesia for Gynecologic Surgical Laparoscopic Procedures</brief_title>
  <official_title>The Role of Curarization During Anesthesia for Gynecologic Surgical Laparoscopic Procedures: a Double Blind Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Campus Bio-Medico University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Campus Bio-Medico University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary outcome of this study is to investigate whether deep NMB reversed with Sugammadex
      is superior to moderate NMB reversed with Neostigmine, in terms of overall pain in the first
      48 hrs after laparoscopic gynecologic surgery, reversal time from NMB (TOF≥0.9) and direct
      and indirect costs. Additionally we will also assess: drugs consumption for pain and
      antiemetics (rescue dose), surgical conditions, hemodynamic and respiratory stability,
      operation time, anesthesia time, total amount and flow rate of CO2, insufflation time,
      resolution of post-operative ileus, dry mouth and PONV in the first 48 hours, patient
      satisfaction.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 20, 2018</start_date>
  <completion_date type="Anticipated">January 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall pain in the first 48 hrs after gynecologic surgical procedures</measure>
    <time_frame>First 48 hrs after gynecologic surgical procedures</time_frame>
    <description>0-10 NRS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recovery time (or Reversal time) from NMB (TOF≥0.9)</measure>
    <time_frame>Recovery time (or Reversal time) from NMB (TOF≥0.9) will be measured after the administration of reversal agent at the end of the surgical procedure.</time_frame>
    <description>Recovery time (or Reversal time) from NMB (TOF≥0.9), measured in minutes from to administration of reversal agent to a TOF≥0.9</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Curarization, Postoperative Residual</condition>
  <arm_group>
    <arm_group_label>SUG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>NEO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sugammadex</intervention_name>
    <description>Reversal of deep NMB</description>
    <arm_group_label>SUG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neostigmine</intervention_name>
    <description>Reversal of moderate NMB</description>
    <arm_group_label>NEO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age 18-75 years BMI between 16 and 40 Kg/m2 ECOG Performance Status tra 0 e 1 American
        Society Anesthesiologist (ASA) class 1 or 3 Able to provide informed consent to trial
        procedures

        Exclusion Criteria:

          -  Age &lt; 18 or &gt; 75 years

          -  BMI &lt;16 o &gt; 40 Kg/m2

          -  ECOG Performance Status &gt;1

          -  Pregnancy

          -  Active or recent pelvic inflammation

          -  Anticipated airway difficulty

          -  Patients with history of allergy to rocuronium, neostigmine or sugammadex

          -  Allergy to NSAIDs

          -  Previous opioids consumption for chronic pain

          -  Patients receiving drugs for different medical conditions, that may prolong or shorten
             the duration of rocuronium effect (e.g aminoglycosides, magnesium)

          -  Hepatic or renal failure

          -  Persistent coagulopathy

          -  Neurological or cognitive disorders

          -  Conversion from laparoscopic to open surgery Onset of intraoperative complications
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Campus Bio-medico</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corrado Terranova</last_name>
      <phone>06225411203</phone>
      <phone_ext>+39</phone_ext>
      <email>c.terranova@unicampus.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2018</study_first_submitted>
  <study_first_submitted_qc>April 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2018</study_first_posted>
  <last_update_submitted>May 11, 2018</last_update_submitted>
  <last_update_submitted_qc>May 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Campus Bio-Medico University</investigator_affiliation>
    <investigator_full_name>Corrado Terranova</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delayed Emergence from Anesthesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neostigmine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

